Adaptive Phage Therapeutics announces collaboration and license agreement with IPTC

Adaptive Phage Therapeutics announces a collaboration and license agreement with the Israeli Phage Therapy Center at Hebrew University and Hadassah Medical Center. The agreement grants APT exclusive rights to make, use and sell licensed phages for human therapy, with sublicensing rights.